© 1993 Oxford University Press
RESEARCH-ARTICLE |
FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit
1MGCDepartment of Human Genetics, Leiden University Wassenaarseweg 72, 2333 AL Leiden, The Netherlands 2Department of Neurology, Leiden University Wassenaarseweg 72, 2333 AL Leiden, The Netherlands 3Department of Structural and Cell Biology, University of Manchester Manchester, UK
*To whom correspondence should be addressed
Received July 23, 1993; Revised September 27, 1993; Accepted September 27, 1993
Facloscapulohumeral muscular dystrophy (FSHD) is a neuromuscular disorder characterized by progressive weakness of the facial, shoulder and upper arm muscles. The disease is associated with DNA rearrangements which are detectable using probe p13E-11 (D4F104S1) in DNA digested with EcoRI or other restriction enzymes. We have cloned and characterized the rearranged EcoRI fragment of four unrelated FSHD patients. Restriction fragment mapping and DNA sequence analysis showed that the proximal and distal parts of the EcoRI fragment, which flank a region of tandemly repeated 3.2 kb units, are identical in normal and rearranged EcoRI fragments. These results strongly support the hypothesis that the FSHD associated rearrangements are due to deletions of Integral copies of the 3.2 kb repeated unit. Since these repeated units are likely to form part of the FSHD transcription unit, the variation in repeat unit number might affect the function of the gene product. Hence, our data confine the FSHD gene region and thus provide a starting point for cloning the FSHD gene.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. P. Chadwick DXZ4 chromatin adopts an opposing conformation to that of the surrounding chromosome and acquires a novel inactive X-specific role involving CTCF and antisense transcripts Genome Res., August 1, 2008; 18(8): 1259 - 1269. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tsumagari, L. Qi, K. Jackson, C. Shao, M. Lacey, J. Sowden, R. Tawil, V. Vedanarayanan, and M. Ehrlich Epigenetics of a tandem DNA repeat: chromatin DNaseI sensitivity and opposite methylation changes in cancers Nucleic Acids Res., April 1, 2008; 36(7): 2196 - 2207. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Petrov, J. Allinne, I. Pirozhkova, D. Laoudj, M. Lipinski, and Y. S. Vassetzky A nuclear matrix attachment site in the 4q35 locus has an enhancer-blocking activity in vivo: Implications for the facio-scapulo-humeral dystrophy Genome Res., January 1, 2008; 18(1): 39 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. de Greef, M. Wohlgemuth, O. A. Chan, K. B. Hansson, D. Smeets, R. R. Frants, C. M. Weemaes, G. W. Padberg, and S. M. van der Maarel Hypomethylation is restricted to the D4Z4 repeat array in phenotypic FSHD Neurology, September 4, 2007; 69(10): 1018 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
N S T Thomas, K Wiseman, G Spurlock, M MacDonald, D Ustek, and M Upadhyaya A large patient study confirming that facioscapulohumeral muscular dystrophy (FSHD) disease expression is almost exclusively associated with an FSHD locus located on a 4qA-defined 4qter subtelomere J. Med. Genet., March 1, 2007; 44(3): 215 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Osborne, S. Welle, S. L. Venance, C. A. Thornton, and R. Tawil Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy Neurology, February 20, 2007; 68(8): 569 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Deak, R. J.L.F Lemmers, J. M. Stajich, R. Klooster, R. Tawil, R. R. Frants, M. C. Speer, S. M. van der Maarel, and J. R. Gilbert Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4 Neurology, February 20, 2007; 68(8): 578 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kawamura-Saito, Y. Yamazaki, K. Kaneko, N. Kawaguchi, H. Kanda, H. Mukai, T. Gotoh, T. Motoi, M. Fukayama, H. Aburatani, et al. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation Hum. Mol. Genet., July 1, 2006; 15(13): 2125 - 2137. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Petrov, I. Pirozhkova, G. Carnac, D. Laoudj, M. Lipinski, and Y. S. Vassetzky Chromatin loop domain organization within the 4q35 locus in facioscapulohumeral dystrophy patients versus normal human myoblasts PNAS, May 2, 2006; 103(18): 6982 - 6987. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M Lovering, N. C Porter, and R. J Bloch The Muscular Dystrophies: From Genes to Therapies Physical Therapy, December 1, 2005; 85(12): 1372 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Diab, B. T. Darras, and F. Shapiro Scapulothoracic Fusion for Facioscapulohumeral Muscular Dystrophy J. Bone Joint Surg. Am., October 1, 2005; 87(10): 2267 - 2275. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Shahrizaila and A J Wills Significance of Beevor's sign in facioscapulohumeral dystrophy and other neuromuscular diseases J. Neurol. Neurosurg. Psychiatry, June 1, 2005; 76(6): 869 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Rijkers, G Deidda, S van Koningsbruggen, M van Geel, R J L F Lemmers, J C T van Deutekom, D Figlewicz, J E Hewitt, G W Padberg, R R Frants, et al. FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients J. Med. Genet., November 1, 2004; 41(11): 826 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tam, K. P. Smith, and J. B. Lawrence The 4q subtelomere harboring the FSHD locus is specifically anchored with peripheral heterochromatin unlike most human telomeres J. Cell Biol., October 25, 2004; 167(2): 269 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Masny, U. Bengtsson, S.-A. Chung, J. H. Martin, B. van Engelen, S. M. van der Maarel, and S. T. Winokur Localization of 4q35.2 to the nuclear periphery: is FSHD a nuclear envelope disease? Hum. Mol. Genet., September 1, 2004; 13(17): 1857 - 1871. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.L. van der Kooi, O.J.M. Vogels, R.J.G.P. van Asseldonk, E. Lindeman, J.C.M. Hendriks, M. Wohlgemuth, S.M. van der Maarel, and G.W. Padberg Strength training and albuterol in facioscapulohumeral muscular dystrophy Neurology, August 24, 2004; 63(4): 702 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Y. Wu, Z.-Q. Wang, S.-X. Murong, and N. Wang FSHD in Chinese population: Characteristics of translocation and genotype-phenotype correlation Neurology, August 10, 2004; 63(3): 581 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Goto, I Nishino, and Y K Hayashi Very low penetrance in 85 Japanese families with facioscapulohumeral muscular dystrophy 1A J. Med. Genet., January 1, 2004; 41(1): e12 - 12. [Full Text] [PDF] |
||||
![]() |
S. T. Winokur, Y.-W. Chen, P. S. Masny, J. H. Martin, J. T. Ehmsen, S. J. Tapscott, S. M. van der Maarel, Y. Hayashi, and K. M. Flanigan Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation Hum. Mol. Genet., November 15, 2003; 12(22): 2895 - 2907. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Bickmore and S. M. van der Maarel Perturbations of chromatin structure in human genetic disease: recent advances Hum. Mol. Genet., October 15, 2003; 12(90002): R207 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wohlgemuth, R. J. Lemmers, E. L. van der Kooi, M. J. van der Wielen, P. G. van Overveld, H. Dauwerse, E. Bakker, R. R. Frants, G. W. Padberg, and S. M. van der Maarel Possible phenotypic dosage effect in patients compound heterozygous for FSHD-sized 4q35 alleles Neurology, October 14, 2003; 61(7): 909 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Kissel, M. P. McDermott, J. R. Mendell, W. M. King, S. Pandya, R. C. Griggs, and R. Tawil Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy Neurology, October 23, 2001; 57(8): 1434 - 1440. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Jo, B. Rutten, R. C. Bunn, and D. S. Bredt Actinin-Associated LIM Protein-Deficient Mice Maintain Normal Development and Structure of Skeletal Muscle Mol. Cell. Biol., March 1, 2001; 21(5): 1682 - 1687. [Abstract] [Full Text] |
||||
![]() |
P. G.M. v. Overveld, R. J.F.L. Lemmers, G. Deidda, L. Sandkuijl, G. W. Padberg, R. R. Frants, and S. M. van der Maarel Interchromosomal repeat array interactions between chromosomes 4 and 10: a model for subtelomeric plasticity Hum. Mol. Genet., November 1, 2000; 9(19): 2879 - 2884. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Felice, W. A. North, S. A. Moore, and K. D. Mathews FSH dystrophy 4q35 deletion in patients presenting with facial-sparing scapular myopathy Neurology, May 23, 2000; 54(10): 1927 - 1931. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M van der Maarel, G. Deidda, R. J L F Lemmers, E. Bakker, M. J R van der Wielen, L. Sandkuijl, J. E Hewitt, G. W Padberg, and R. R Frants A new dosage test for subtelomeric 4;10 translocations improves conventional diagnosis of facioscapulohumeral muscular dystrophy (FSHD) J. Med. Genet., November 1, 1999; 36(11): 823 - 828. [Abstract] [Full Text] |
||||
![]() |
P. Pomies, T. Macalma, and M. C. Beckerle Purification and Characterization of an alpha -Actinin-binding PDZ-LIM Protein That Is Up-regulated during Muscle Differentiation J. Biol. Chem., October 8, 1999; 274(41): 29242 - 29250. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Orrell, R. Tawil, J. Forrester, J. T. Kissel, J. R. Mendell, and D. A. Figlewicz Definitive molecular diagnosis of facioscapulohumeral dystrophy Neurology, June 1, 1999; 52(9): 1822 - 1822. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mazzarella and D. Schlessinger Pathological Consequences of Sequence Duplications in the Human Genome Genome Res., October 1, 1998; 8(10): 1007 - 1021. [Abstract] [Full Text] |
||||
![]() |
H. Xia, S. T. Winokur, W.-L. Kuo, M. R. Altherr, and D. S. Bredt Actinin-associated LIM Protein: Identification of a Domain Interaction between PDZ and Spectrin-like Repeat Motifs J. Cell Biol., October 20, 1997; 139(2): 507 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Purandare and P. I. Patel Recombination Hot Spots and Human Disease Genome Res., August 1, 1997; 7(8): 773 - 786. [Full Text] [PDF] |
||||











